The Myc oncogene, which was most highly associated with binding sites common to ERα and PR, is a known target of both estrogen and progesterone and plays a key role in the normal breast and breast cancer (Curtis et al., 2012; Hynes & Stoelzle, 2009). Here, MYC is linked to breast carcinoma.